Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pediatrics ; 112(3 Pt 1): 628-33, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12949294

RESUMO

BACKGROUND: A subtype of antenatal Bartter syndrome and sensorineural deafness (BSND) was originally described among families from southern Israel, and its gene (Barttin, OMIM #606412) has recently been identified. A report has suggested that these children develop chronic renal insufficiency during childhood attributable to chronic tubulointerstitial fibrosis and atrophy. METHODS: Data from 13 infants with BSND, who were born during a 20-year period in our institution, were retrospectively analyzed. RESULTS: All pregnancies were complicated by polyhydramnion and premature birth. All patients have sensorineural deafness, as well as hypokalemic metabolic alkalosis. Persistent hypercalciuria or nephrocalcinosis were absent in most children. All children have been treated with indomethacin (2 mg/kg/d) and potassium supplementation. The current average serum creatinine and calculated creatinine clearance from the older group (n = 8; mean age: 8.8 +/- 1.4 years) is 60.8 +/- 16.5 micro mol/L and 95 +/- 20 mL/min/1.73m(2), respectively. Kidney biopsies from two 7-year-old patients revealed mild focal tubulointerstitial fibrosis and minimal mesangial proliferation but no glomerulosclerosis. CONCLUSIONS: Early renal function deterioration is not a uniform finding among children with BSND mutations.


Assuntos
Perda Auditiva Neurossensorial/diagnóstico , Síndrome de Secreção Inadequada de HAD/diagnóstico , Falência Renal Crônica/prevenção & controle , Anti-Inflamatórios não Esteroides/uso terapêutico , Árabes/genética , Cromossomos Humanos Par 1/genética , Suplementos Nutricionais , Feminino , Hidratação/métodos , Efeito Fundador , Perda Auditiva Neurossensorial/genética , Humanos , Síndrome de Secreção Inadequada de HAD/dietoterapia , Síndrome de Secreção Inadequada de HAD/tratamento farmacológico , Síndrome de Secreção Inadequada de HAD/genética , Indometacina/uso terapêutico , Recém-Nascido , Recém-Nascido Prematuro , Masculino , Potássio na Dieta/uso terapêutico , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA